PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

W ielopierścieniowe węglowodory aromatyczne (substancje smołowe rozpuszczalne w cykloheksanie). Dokumentacja proponowanych wartości dopuszczalnych poziomów narażenia zawodowego

Autorzy
Wybrane pełne teksty z tego czasopisma
Identyfikatory
Warianty tytułu
EN
Polycyclic aromatic hydrocarbons
Języki publikacji
PL
Abstrakty
PL
W latach 1980 i 1984 eksperci z EPA za decydujący dla ustalenia wielkości ryzyka nowotworowego w odniesieniu do WWA uznali podział tych związków na rakotwórcze i nierakotwórcze. Podjęto próbę zastosowania do całej klasy WWA wartości SF wyznaczonego dla benzo(a)pirenu. W przeszłości podobny sposób postępowania przyjęto w celu obliczenia ryzyka związanego z narażeniem na PCDD i PCDF. W koncepcji tej założono, że B(a)P jest związkiem wzorcowym, a siła działania rakotwórczego (nazwana względnym współczynnikiem kancerogenności - WWK) innych związków obliczana jest w stosunku do B(a)P. Wartość WWK równa 0 oznacza brak aktywności rakotwórczej związku. Rozwinięcie tej koncepcji i zastosowanie odpowiedniego modelu matematycznego do obliczenia WWK na podstawie dostępnych wyników badań przeprowadzili Nisbet i LaGoy (1992). Tylko dibenzo(a,h)antracen ma wartość WWK większą od jedności. Wartości WWK dla 4 związków rakotwórczych z grupy WWA wynosiły 0,1; dla trzech innych 0,01; WWK dla pozostałych związków wynosi 0,001. Nisbet i LaGoy analizując wyniki badań Pfeiffera (1977) zastosowali wyznaczone przez siebie wartości WWK do obliczenia oczekiwanej liczby przypadków nowotworów. Stwierdzili, że szczególnie w zakresie niskich dawek liczba oczekiwanych przypadków nowotworów była zgodna z tymi, jakie uzyskano w warunkach doświad¬czalnych. Liczne badania epidemiologiczne wykonane u pracowników narażonych na wielopierścieniowe węglowodory aromatyczne (WWA), w tym również benzo(a)piren, wykazały wyraźną zależność między narażeniem na te mieszaniny i wzrostem ryzyka powstawania nowotworów. W środowisku pracy WWA występują w powietrzu w postaci par lub aerozoli. Znajdujące się w powietrzu WWA najczęściej osadzone są na pyle.
EN
In the years 1980-1984 to establish the scale of neoplastic risk in relation to PAH, EPA experts acknowledged division of these compounds into carcinogenic and non-carcinogenic. An attempt has been undertaken to apply B(a)P determined for SF value for the whole PAH class. In the past, similar way of procedure was accepted in order to calculate the risk connected with exposure to PCDD and PCDF. In this conception, it was assumed that B(a)P is a model compound and the force of carcinogenic activity (called carcinogenity relative coefficient - CRC) of other compounds is calculated in relation to B(a)P. CRC value = 0 stands for the lack of carcinogenic activity of the compound. Nisbet and LaGoy (1992) developed this conception and applied an adequate mathematical model for CRC calculation on the basis of available results of investigations. Only dibenzo(a,h)antracen has CRC value > 1. CRC value for four carcinogenic compounds from PAH group is 0,1; for other three 0,01 and for the remaining compounds 0,001. Nisbet and LaGoy, analysing Pfeiffer’s (1977) results of investigations, applied determined by themselves CRC values to calculate expected number of neoplastic cases. They stated that particularly in the range of low doses, the number of expected neoplastic cases was in accor¬dance with those obtained in experimental conditions. Numerous epidemiologic investigations performed in employees exposed to polynuclear aromatic hydrocarbons (PAHs), including benzo(a)pyrene showed distinct dependence between exposure to these mixtures and increase of the risk of neoplasms development. In work envi- ronment PAHs are found in the air in the form of vapours or aerosols and are most frequently deposited on dust particles. nte-
Rocznik
Tom
Strony
179--208
Opis fizyczny
Bibliogr. 113 poz., tab.
Twórcy
autor
  • Akademia Medyczna 90-419 Łódź al. T. Kościuszki 4
Bibliografia
  • 1. ACGIH (1998) Threshold limit values for chemical substances and physical agents and biological exposure indices. American Conference of Govermental Industrial Hygienists. Cinccinnati, OH.
  • 2. Adlkofer F. i in. (1990) Dietary influences on urinary excretion of hydroxyohenanthrenes, thioethers and mutagenicity in man. IARC, 415-419.
  • 3. Ball L. i in. (1989) Bacterial mutagenicity of new cyclopenta-fused cata-annelated polycyclic aroma- toc hydrocarbons, and identification of the major metabolites of benz(j)acephenanthrylene formed by Arclor-treated rat liver microsomes. Mut. Res. 224: 115-125.
  • 4. Bonassi S., Merlo F., Puntoni R. (1989) Bladder cancer and occupational exposure to polycyclic aromatic hydrocarbons. Int. J. Cancer, 44: 648-651.
  • 5. Brandt P., Smith S., Perera F. (1990) Serum oncogene proteins in foundry workers. J. Soc. Occup. Med., 40: 11-14.
  • 6. Braszczyńska Z, Osińska R., Linscheid D. (1981) Kształtowanie się poziomów stężeń wielopierścieniowych węglowodorów aromatycznych w wybranych zakładach produkcyjnych. Przeg. Lek. 38, 9:667-671.
  • 7. Brzeźnicki S. (1995) Przebadanie kinetyki wydalania 1-hydroksypirenu w moczu oraz retencji pirenu w płucach w warunkach zawodowej ekspozycji na wielopierścieniowe węglowodory aromatyczne. Grant Promotorski No 4 P05D 023 08, IMP.
  • 8. Brzeźnicki S., Jakubowski M. (1993) Ocena przydatności oznaczeń 1-hydroksypirenu w moczu oraz innych możliwych testów ekspozycyjnych do określania narażenia na WWA. Med. Pracy, XLIV(4), 355-362.
  • 9. Brzeźnicki S., Jakubowski M, Czerski B. (1997) Elimination of 1-hydroxypyrene After Human Volunteer Exposure to Polycyclic Aromatic Hydrocarbons. Int. Arch. Occup. Environ. Health, 70, 257-260.
  • 10. Bucket J.P. i in. (1992) Evaluation of exposure to polycyclic aromatic hydrocarbons in a coke production and a graphite electrode manufacturing plan: assessment of urinary excretion of 1-hydroxypyrene as a biological indicator of exposure. Brit. J. Ind. Med. 49, 761-768.
  • 11. Buckley T.J., Lioy P.J. (1992) An examination of the time course from human dietary exposure to polycyclic aromatic hydrocarbons to urinary elimination of 1-hydroxypyrene. Brit. J. Ind. Med. 49, 113-124.
  • 12. Caporaso N. i in.(1989) Lung cancer risk, occupational exposure, and debrisoquine metabolic pheno¬type. Cancer Research, 49: 3675-3679.
  • 13. Clonfero E. i in. (1990) Biological monitoring of human exposure to coal tar. Urinary mutagenicity assays and analytical determination of polycyclic aromatic hydrocarbon metabolities in urine. IARC, 215-221.
  • 14. Clonfero E., Zordan M.} Venier P. (1989) Urinary excretion of total polycyclic aromatic hydrocarbons, 1-hydroxypyrene and mutagenes in psoriatic patients. Int.Arch. Occup. Environ. Health, 61: 363-368.
  • 15. Coggon D. i in. (1989) Lung cancer in the meat industry. Brit. J. Ind. Med. 46: 188-191.
  • 16. Collins J.F. i in. (1991) Risk assessment for benzo(a)pyrene. Regulatory Toxicol. Pharmacol. 13: 170- 184.
  • 17. Complex Mixtures and Cancer Risk (1990) IARC Publications No 104.
  • 18. Cottini G.B., Mazzone G.B. (1939) The effects of 3,4-benzpyrene on human skin. Am. J. Cancer 37: 186-195. [Cyt. za Complex Mixtures..., 1990; Toxicological Profile..., 1995].
  • 19. Dutkiewicz T., Ryborz S., Masłowski J. (1983) Ocena narażenia populacji ludzkich na tle zanieczyszczenia środowiska wielopierścieniowymi węglowodorami aromatycznymi (WWA). Przeg. Lek. 40, 8: 631-633.
  • 20. Elovaara i in. (1995) Significance of dermal respiratory uptake in creosote workers: exposure to polycyclic aromatic hydrocarbons and urinary excretion of 1-hydroxypyrene. Occup. Environ. Med. 52, 196-203.
  • 21. Granella M., Clonfero E. (1991) The mutagenic activity and polycyclic aromatic hydrocarbon content of mineral oils. Int. Arch. Occup. Environ. Health, 63: 149-153.
  • 22. Gromiec J., Krajewski J., Barański B. (1981) Problemy ekspozycji zawodowej na mgłę olejową przy stosowaniu płynów obróbkowych. Med. Pracy, 5: 359-363.
  • 23. Gustavsson P., Gustavsson A., Hogstedt C. (1988) Excess of cancer in Swedish chimney sweeps. Brit. J. Ind. Med. 45: 777-781.
  • 24. Hall M., Grover P. (1988) Stereoselective aspects of the metabolic activation of benzo(a)pyrene by human skin in vitro. Chem. Biol. Interactions, 64: 281-296.
  • 25. Hattemer-Frey H., Travis C. (1991) Benzo-a-pyrene: Environmental partitioning and human exposure. Toxicol. Ind. Health, 7(3): 141-157.
  • 26. Hawkins W. (1990) Carcinogenic effects of some polycyclic aromatic hydrocarbons on the japanase medika and guppy in waterborne exposures. The Science of the Total Environmental, 94: 155-167.
  • 27. Hemminki K. i in. (1990a) DNA adducts in humans environmentally exposed to aromatic compounds in an industrial area of Poland. Carcinogenesis, 11, 7: 1229-1231.
  • 28. Hemminki K. i in. (1990b) DNA adducts in humans related to occupational and environmental exposure to aromatic compounds. IARC, 181-191.
  • 29. Hemminki K.t Randerath K, Reddy M. (1990) Postlabelling and immunoassay analysis of polycyclic taromatic hydrocarbons - adducts of deoxyribonucleic acid in white blood cells of foundry workers. Scand. J. Environ. Health, 16: 158-162.
  • 30. Herbert R., Marcus M., Wolff M. (1990) Detection of adducts of deoxyribonucleic acid in white blood cells of roofers by 32-P-postlabeling. Scand. J. Environ. Health, 16: 135-143.
  • 31. Herbert R. i in. (1990) A pilot study of detection of DNA adducts in white blood cells of roofers by 32-P-postlabeling. IARC. 205-213.
  • 32. Howard P. i in. (1990) The metabolism of 1-nitropyrene by human cytochromes P450. Carcinogenesis, 11,9: 1539-1542.
  • 33. Hughes N., Philips D. (1990) Covalent binding of dibenzpyrenes and benzo(a)pyrene to DNA: evidence for synergistic and inhibitory interactions when applied in combination to mouse skin. Carcino¬genesis, 11,9: 1611-1619.
  • 34. IARC (1983) Monographs on the Carcinogenic Risk of Chemicals to Humans Vol. 32. Polynuclear Aromatic Compounds. Part 1. Chemical, Environmental and Experimental Data. Lyon.
  • 35. IARC (1989) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol. is, 34. Polynuclear Aromatic Compounds. Part 3. Industrial Exposure in Aluminium Production, Coal Gasification Coke Production and Iron and Steel Founding. IARC: Lyon.
  • 36.Jacob J. i in. (1982) The Metabolism of Pyrene by Rat Liver Microsome and the Influence of Various }Mono-oxygenase Inducers: Xenobiotica, vol. 12, No 1,45-53.
  • 37. Jongeneelen F.J.(1992) Biological exposure limit for occupational exposure to coal tar pitch volatiles at cokeovens. Occup. Environ. Health. 63, 511-516.
  • 38. Jongeneelen F.J. i in. (1988) 1-Hydroxypyrene in urine as a biological indicator of exposure to polycyclic aromatic hydrocarbons in several work environments. Ann. Occup. Hyg. 32, 1, 35-43.
  • 39. Jongeneelen F. I in. (1990) Ambient and biological monitoring of cokeoven workers determinants of the internal dose of polycyclic aromatic hydrocarbons. Brit. J. Ind. Med. 47: 454-461.
  • 40. Jongeneelen F.J., Bos R.P., Grimmer G. (1990) Excretion of pyrene and hydroxypyrene in urine Cancer Letters, 51, 175-179.
  • 41. Jongeneelen F.J., Bos R.P., Henderson P.T.H. (1988) Metabolites of polycyclic Aromatic Hydrocarbons in urine of exposed workers. Toxicol. Environ. Chem. 16, 295-307.
  • 42. Jongeneelen F.J., Van Rooij G.M. (1993) Biological monitoring of polycyclic aromatic hydrocarbons: environmental health aspect related to the to the production of aluminium. Book of Abstracts. Bergen, Norwegia.
  • 43. Knecht U.f Blom-Audorff U., Woitowitz H. (1989) Atmospheric concentrations of polycyclic aromatic hydrocarbons during chimney sweeping. Brit. J. Ind. Med. 46: 479-482.
  • 44. Kubasiewicz M, Starzyński Z. (1987) Rak skóry w Polsce a czynniki środowiska pracy. Med. Przemysłowa, 6:441-446.
  • 45. Kubasiewicz M, Starzyński Z (1989) Case-referent study on skin cancer and its relation to occupational exposure to polycyclic aromatic hydrocarbons. I. Study design. Pol. J. Occup. Med., 2, 3: 221-228.
  • 46. Lecoq S. i in. (1989) Comparison of the in vitro metabolisms and mutagenicities of dibenzo(a.c)anthracene, dibenzo(a,h)anthracene and dibenzo(a,j)-anthracene: influence of norharman. Carcinogenesis, 10, 3: 461-469.
  • 47. Lee B. i in. (1991) Immunologic measurment of polycyclic aromatic hydrocarbon-albumin adducts in u foundry workers and roofers. Scand. J. Work Environ. Health, 17: 190-194.
  • 48. Levin J.O. (1995) First International Workshop of Hydroxypyrene as Biomarker for PAH Exposure in Man. Sci. Total Environ. 163, 163-168.
  • 49. Lipniak M., Brandys J., Moniczewski A. (1990) Wiązanie niektórych wielopierścieniowych węglowodorów aromatycznych (WWA) z albuminą osocza i elementami morfotycznymi krwi. Folia Medica Cracoviensia, XXXI, 1-2: 71-77.
  • 50. Lipniak M., Jawie W. (1988) Wielopierścieniowe węglowodory aromatyczne (WWA) w pyle opadowym. Roczn. PZH, XXXIX, 2: 156-160.
  • 51. Lloyd J.W. (1971) Long-therm Mortality Study of Steelworkers. Respiratory Cancer in Coke Plant. J. Occup. Med. 13, 53-68.
  • 52. Lubet R., Guengerich F., Nims R. (1990) The induction of alkoxyresorufin metabolism: a potential indicator of environmental contamination. Arch. Environ. Toxicol. 19: 157-163.
  • 53. Lutz W., Sułkowski W. (1989) Bioaktywacja ksenobiotyków przez cytochromy P-448 i ich udział w procesie kancerogenezy. Post. Hig. Dośw. 43, 5-6: 511-539.
  • 54. Mane S., Purnell D., Hsu C. (1990) Genotoxic effects of five polycyclic aromatic hydrocarbons in human and rat mammary epithelial cells. Environ. Molecul. Mut., 15: 78-82.
  • 55. Masento M. i in. (1989) Enzyme-mediated phosphorylation of polycyclic hydrocarbon metabolites: detection of non-adduct compounds in the 32-P-postlabelling assay. Carcinogenesis, 10: 1557-1559.
  • 56. Mazumdar S. i in. (1975) An Epidemiological Study of Exposure to Coal Tar Pitch Volatiles Among Coke Oven Workers. J.Air Pollut. Control Assoc. 25, 382-389.
  • 57. Mersch-Sundermann VKern S., Wintermann F. (1991) Genotoxicity of nitrated polycyclic aromatic hydrocarbons and related structures on escherichia coli PQ37 (SOS Chromotest). Environ. Molecul. Mut., 18: 41-50.
  • 58. Modica R.i in. (1983) Comparative kinetics of benz(a)anthracene, chrysene and triphenylene in rats after oral administration. Toxicol. Lett., 18: 103-109.
  • 59. Monitoring Human Exposure to Carcinogenic and Mutagenic Agents (1984) IARC Publication No 59.
  • 60. Moore C, Tricomi W, Gould M. (1986) Interspecies comparison of polycyclic aromatic hydrocarbon metabolism in human and rat mammary epithelial cells. Can. Res., 10: 4946-4952.
  • 61. Motykiewicz G. i in. (1990) Mutagenic activity of complex air pollutants in Silesia. IARC, 261-268.
  • 62. Moulin J. i in. (1990) Etude cas-temoins sur le risque de cancer dans quatre cohortes de salaries de I'industrie productrice d'electrodes en carbone. Arch. Mai. Prof., 1: 55-60.
  • 63. Nisbet l.C.T, LaGoy PK. (1992) Toxic (TEFs) for polycyclic aromatic hydrocarbons (PAHs). Reg. Toxicol. Pharmacol. 16: 290-300.
  • 64. NRC (1983) Polycyclic Aromatic Hydrocarbons: Evaluation of Sources and Effects. Washington National Academy Press ES/I-ES17.
  • 65. Ny E.Y. i in. (1993) The Relationship Between Polycyclic Aromatic Hydrocarbons in Air and urine of Workers in a Soderberg Potroom Adv. Ind. Environ. Hyg. 54, 6, 277-284.
  • 66. Obiedziński M. (1985) Wybrane zagadnienia zanieczyszczenia żywności wielopierścieniowymi węglowodorami aromatycznymi (WWA). Postępy Hig. Dośw., 39: 660-676.
  • 67. Ovrebo S. i in. (1990) Polycyclic aromatic hydrocarbon-DNA adducts in coke-oven workers. IARC, 193-198.
  • 68. Pahlman R. (1988) Mutagenicity of naphthacene, a non-bay-region aromatic hydrocarbon, in Salmonella. Mut. Res. 207:205-221.
  • 69. Paint A., Knapp R., Smith L. (1987) Mechanism and rate of permeation of cells by polycyclic aromatic hydrocarbons. J. Biol. Chem. 262, 6: 2514-2519.
  • 70. Pelkonen O., Nebret D. (1982) Metabolism of polycyclic aromatic hydrocarbons: etiologie role in carcinogenesis. Pharm. Rev. 34, 2.
  • 71. Perera F. i in. (1988) Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers. Cancer Research, 48: 2288-2291.
  • 72. Peter P. (1990) Metabolism of nitro-polycyclic aromatic hydrocarbons. Drug Metabolism Reviews, 22, 2-3, 209-268.
  • 73. Pfeiffer E.H. (1977) Oncogenic interaction of carcinogenic and non-carcinogenic polycyclic aromatic hydrocarbons in mice: IARC Scientific Publication No. 16. Air pollution and cancer in man. Lyon, France: International Agency for Research on Cancer, 69-77.
  • 74. Philips D. i in. (1990) DNA adduct formation in human and mouse skin by mixtures of polycyclic aromatic hydrocarbons. IARC, 223-229.
  • 75. Pierson W., Koening J. (1989) Potential adverse health effects of wood smoke. Environ. Health, 151: 339-342.
  • 76. Pilarska-Machowicz A. (1990) Rola hydroksylazy węglowodorów aromatycznych w patogenezie raka płuca. Pol. Tyg. Lek. XLV, 14-15: 303-307.
  • 77. Platt K., Pfeiffer E.Pertovic P. . (1990) Comparative tumorigenicity of pirene and di- benz(a,h)anthracene in the mouse. Carcinogenesis, 11, 10: 1721-1726.
  • 78. Pott F., Heinrich U. (1990) Relative significance of different hydrocarbons for the carcinogenic potency of emissions form various incomplete combustion processes. IARC, 228-297.
  • 79. Raat W.y Kooijman S., Gielen J. (1987) Concentrations of polycyclic hydrocarbons in airborne particles in the netherlands and their correlation with mutagenicity. The Science of the Environ. 66: 95-114.
  • 80. Reddy M., Hemminki K., Randerath K. (1991) Postlabelling analysis of polycyclic aromatic hydrocar- bon-DNA adducts in white blood cells of foundry workers. J. Toxicol. Environ. Health, 34:177-185.
  • 81. Redmond E., Strobino B., Cypress R. (1976) Cancer Experience Among Coke By-product Workers. Ann. N.Y. Acad. Sci. 271, 102-115.
  • 82. Research and Development Health Effects Assessment for Benzo(a)Pyrene (1984) Prepared by Environmental Criteria and Assessment Office, Cincinnati OH 45268.
  • 83. Reuterwall C., Ariger L., Elinder C. (1991) Assessment of genotoxic exposure in Swedish coke- oven work by different methods of biological monitoring. Scand. J. Work Environ. Health, 17: 123-132.
  • 84. Richard A., Woo Y. (1990) A CASE-SAR analysis of polycyclic aromatic hydrocarbon carcinogenicity. Mut. Res. 242: 285-303.
  • 85. Roberts E. i in. (1990) Characterization of the ah receptor mediating aryl hydrocarbon hydroxylase induction in the human liver cell line hep G2. Archives of Biochemistry and Biophysics, 276, 2: 442- 450.
  • 86. Romert L. i in. (1989) Effects of glutathione transferase activity on benzo(a)pyrene 7,8-dihydrodiol metabolism and mutagenesis studied in a mammalian cell co-cultivation assay. Carcinogenesis, 10, 9: 1701-1707.
  • 87. Sama R. i in. (1990) Cancer incidence among Massachusetts firefighters, 1982-1986. Am. J. Ind. Med. 18: 47-54.
  • 88. Sarto F. i in. (1989) Chromosomal alternations in peripheral blood lymphocytes, urinary mutagenicity and extretion of polycyclic aromatic hydrocarbons in six psoriatic patients undergoing coal tar therapy. Carcinogenesis, 10, 2: 329-334.
  • 89. Schoket B. i in. (1991) 32-P-postlabelling detection of aromatic DNA in peripheral blood lymphocytes from aluminium production plant workers. Mut. Res. 260: 89-98.
  • 90. Sherson D. i in. (1990) Biological monitoring of foundary workers exposed to polycyclic aromatic hydrocarbons. Brit. J. Ind. Med. 47: 448-453.
  • 91. Shmahl D., Schmidt KG., Habs M.K (1977) Syncarcinogenic action of polycyclic aromatic hydrocar¬bons in automobile exhause gas condensates. In: Air Polution and Cancer in Man. IARC Publication No. 16. WHO. Lyon, France, 53-59.
  • 92. Stein J.E. i in. (1990) Overview of studies on liver carcinogenesis in english sole from puget sound; evidence for a xenobiotic chemical etiology II: biochemical studies. The Science of the Total Envi- ronm. 94: 51-69.
  • 93. Strom J. i in. (1990) Metabolism of xenobiotics during percutaneous penetration: Role of absorption rate and Cutaneous enzyme activity. Fund. Appl. Toxicol. 15: 132-141.
  • 94. Substancje rakotwórcze w środowisku pracy. Wielopierścieniowe węglowodory aromatyczne (1987) Łódź.
  • 95. Sułkowski W., Szeszenia-Dąbrowska N., Kowalska S. (1986) Epidemiologia raka zawodowego gór¬nych dróg oddechowych w Polsce w latach 1971-1985. Med. Pracy, XXXVII, 6: 353-361.
  • 96. Surh Y. i in. (1989) Metabolic activation of the carcinogen 6-hydroxymethylbenzo(a)pyrene: forma¬tion of an electrophilic sulfuric acid ester and benzylic DNA adducts in rat liver in vivo and in rela¬tions in vitro. Carcinogenesis, 10, 8: 1519-1528.
  • 97. Szeszenia-Dąbrowska N. i in. (1997) Nowotwory pochodzenia zawodowego w Polsce w latach 1971- 1994. Med. Pracy, 1, 1-14.
  • 98. Szeszenia-Dąbrowska N., Strzelecka A., Wilczyńska U. (1991) Zagrożenie substancjami rakotwórczymi w przemyśle. Ocena sytuacji wraz z propozycją systemu informacyjnego. Med. Pracy, XLII, 1: 59-64.
  • 99. Tols W.P. i in. (1990) 1-Pyrenol: A Biomarker for occupational exposure to polycyclic aromatic hydrocarbons. Appl. Occup. Environ. Hyg. 5, 303-309.
  • 100. Toxicological profile for benzo(a)pyrene (1990) US Department of Health and Human Services.
  • 101. Toxicological Profile for Polycyclic Hydrocarbons (1995) U.S. Department of Health and Human Services. Washington.
  • 102. Van Rooij G.M., Bodelier-Bcide M.M., Jongeneelen F.J. (1993) Estimation of individual dermal and respiratory uptake of polycyclic aromatic hydrocarbons in 12 coke oven workers. Brit. J. Ind. Med. 50, 6623- 632.
  • 103. Wang Z. i in. (1989) Protection against polycyclic aromatic hydrocarbon-induced skin tumor iniciation in mice by green tea polyphenols. Carcinogenesis, 10, 2: 411-415.
  • 104. Weinstein I. i in. (1988) The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment - twenty-seventh G.H.A. Clowes memorial award lecture. Cancer Research, 48: 4135-4143.
  • 105. Wenzel-Hartung R. i in. (1990) Evaluation of the carcinogenic potency of 4 environmental polycyclic aromatic compounds following intrapulmonary application in rats. Exp. Pathol. 40: 221-227.
  • 106. Wester R., Maibach H., Bucks D. (1990) Percutaneous absorption of 14-C-DDT and 14-C- benzo(a)pyrene from soil. Fund. Appl. Toxicol. 15: 510-516.
  • 107. Weyand E.H., Beavan D.R. (1986) Benzo(a)pyrene Disposition and Metabolism in Rats Following Inte- ratracheal Installation. Cancer. Res. 46, 5655-5661.
  • 108. Weyand E. i in. (1990) Relative tumor initiating activity of benzo(a)fluoranthene, ben- zo(b)fluoranthene, naphtho(l,2-b)fluoranthene, and naphto(2,l-a)fluoranthene on mouse skin. Cancer Letters, 52: 229-233.
  • 109. Wilson V. i in. (1989) Alkyl and aryl carcinogen adducts detected in human peripheral lung. Carcino¬genesis, 10, 11: 2149-2153.
  • 110. Wolff R.K. i in. (1989) Effects of Repeated Inhalation exposures to 1-nitropyrene, Benzo(a)pyrene, Ga203 Particles and SO2 Alone and in Combinations on Particle Clearance, Bronchoalveolar Lavage Fluid Composition, and Histopathology. J. Toxicol. Environ. Health., 27,123-138.
  • 111. Xian Yinlin i in. (1987) 1-Hydroksypyrene - The biological monitoring index of occupational exposure to polycyclic aromatic hydrocarbons (inf. własna).
  • 112. Yoshikawa T. i in. (1985) Toxicity of polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharm. 79: 218-226.
  • 113. Zhao Z, Quan W., Tian D. (1990) Urinary 1-hydroxypyrene as in indicator of human exposure to ambient polycyclic aromatic hydrocarnons in a coal-burning environment. The Science of the Total Environ. 92: 145-154.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-b2211a91-3631-4219-9567-8c8b42b0f721
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.